Elanco Animal Health Revenue 2016-2024 | ELAN

Elanco Animal Health annual/quarterly revenue history and growth rate from 2016 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Elanco Animal Health revenue for the quarter ending March 31, 2024 was $1.205B, a 4.14% decline year-over-year.
  • Elanco Animal Health revenue for the twelve months ending March 31, 2024 was $4.365B, a 1.73% decline year-over-year.
  • Elanco Animal Health annual revenue for 2023 was $4.417B, a 0.14% increase from 2022.
  • Elanco Animal Health annual revenue for 2022 was $4.411B, a 7.41% decline from 2021.
  • Elanco Animal Health annual revenue for 2021 was $4.764B, a 45.64% increase from 2020.
Elanco Animal Health Annual Revenue
(Millions of US $)
2023 $4,417
2022 $4,411
2021 $4,764
2020 $3,271
2019 $3,071
2018 $3,067
2017 $2,889
2016 $2,914
2015 $2,909
Elanco Animal Health Quarterly Revenue
(Millions of US $)
2024-03-31 $1,205
2023-12-31 $1,035
2023-09-30 $1,068
2023-06-30 $1,057
2023-03-31 $1,257
2022-12-31 $984
2022-09-30 $1,026
2022-06-30 $1,175
2022-03-31 $1,226
2021-12-31 $1,112
2021-09-30 $1,131
2021-06-30 $1,279
2021-03-31 $1,242
2020-12-31 $1,137
2020-09-30 $890
2020-06-30 $586
2020-03-31 $658
2019-12-31 $787
2019-09-30 $771
2019-06-30 $782
2019-03-31 $731
2018-12-31 $799
2018-09-30 $761
2018-06-30 $770
2018-03-31 $736
2017-12-31
2017-09-30 $697
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $9.014B $4.417B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.426B 11.15
Quest Diagnostics (DGX) United States $15.716B 16.24
DaVita (DVA) United States $12.417B 15.42
Encompass Health (EHC) United States $8.655B 22.16
Chemed (CHE) United States $8.248B 25.57
Option Care Health (OPCH) United States $4.992B 18.90
RadNet (RDNT) United States $4.542B 94.58
Amedisys (AMED) United States $2.987B 21.16
Astrana Health (ASTH) United States $2.206B 29.83
LifeStance Health (LFST) United States $2.045B 0.00
Addus HomeCare (ADUS) United States $1.912B 27.35
U.S Physical Therapy (USPH) United States $1.446B 38.69
Pennant (PNTG) United States $0.687B 36.29
Aveanna Healthcare Holdings (AVAH) United States $0.481B 0.00
Atai Life Sciences (ATAI) Germany $0.234B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.025B 0.00
Novo Integrated Sciences (NVOS) United States $0.019B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00